First Mid Bancshares (FMBH) 10-Q2022 Q1 Quarterly report

Filed: 9 May 22, 4:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Bad

New words: DCF, distribution, drove, inflationary, LGD, likelihood, parent, partnership, PD, regression, Subtopic, tied, Tzedhe, unitt, vintage

Removed: advantage, approach, assist, consultant, continuation, deducted, develop, ease, eighteen, evaluate, evolving, expiring, finalization, functional, gambling, heightened, historically, implementation, lifetime, location, merge, MFP, Notice, notified, order, parallel, percent, preliminary, pressure, reached, Recession, recur, remit, Rulemaking, season, sick, sixty, standard, steady, surcharge, thirty, transitioned, upfront, usage, utilize, validated, validation, waived, write

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

FMBH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification pursuant to 18 U.S.C. section 1350, as adopted pursuant to

In connection with the Quarterly Report of First Mid Bancshares, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matthew K. Smith, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2022

/s/ Matthew K. Smith

Matthew K. Smith

Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.